first glp 1 approval History of GLP-1 Medications Orforglipron FDA Approval: Why the

PMID: 21950636

Efficacy Estimand Change from Baseline HbA1c, source: Additionally, the 12 mg and 36 mg doses demonstrated clinically meaningful and statistically significant reductions in body weight compared to the placebo

Some studies have even found that some people start noticing symptoms of ADHD after starting a GLP-1 drug.opens in a new tab In psychiatry studies, the placebo effect shows up a lot.opens in a new tab Thats when the symptoms of someones condition improve when they take what they think is a medication for that condition but actually isnt

When this occurs: Optic nerve tissue is damaged Visual signals cannot properly reach the brain Vision loss develops rapidly and without warning In most cases, the vision loss caused by NAION is permanent and irreversible

When eating feels less exhausting, healthier routines start to feel doable again

Larsson LI, Holst J, Hakanson R, and Sundler F